NOVEL METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF DYSMENORRHOEA AND MENSTRUAL SIDE EFFECTS: THE USE OF PHOSPHOLIPASE INHIBITORS

摘要

The present invention discloses the use of secretory phospholipases A2 inhibitors in compositions and in methods for modulation of uterine contractions and for reducing or alleviating discomforting symptoms such as pain and blood loss, for the treatment and/or prophylaxis of dysmenorrhoea and related conditions and for the treatment and/or prophylaxis of premature uterine expulsion of a foetus or embryo, impending abortion or miscarriage.